Cooper Companies (NYSE:COO) updated its FY19 earnings guidance on Thursday. The company provided EPS guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.08. The company issued revenue guidance of $2.60-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY 2019 guidance to $11.30-11.70 EPS.
A number of analysts have recently commented on the company. Jefferies Financial Group boosted their price target on Cooper Companies to $305.00 and gave the company a buy rating in a report on Friday. ValuEngine upgraded Cooper Companies from a hold rating to a buy rating in a report on Thursday, September 27th. BMO Capital Markets boosted their price target on Cooper Companies from $294.00 to $306.00 and gave the company an outperform rating in a report on Friday. Zacks Investment Research restated a hold rating and issued a $285.00 price target on shares of Cooper Companies in a report on Monday, November 12th. Finally, Oppenheimer set a $270.00 price target on Cooper Companies and gave the company a hold rating in a report on Friday, August 31st. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Cooper Companies presently has an average rating of Buy and a consensus target price of $284.50.
COO opened at $243.01 on Friday. Cooper Companies has a 52-week low of $216.47 and a 52-week high of $283.18. The stock has a market cap of $13.61 billion, a P/E ratio of 21.13, a P/E/G ratio of 2.13 and a beta of 0.77. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58.
In related news, VP Randal Golden sold 1,731 shares of the company’s stock in a transaction dated Thursday, September 27th. The stock was sold at an average price of $275.86, for a total transaction of $477,513.66. Following the sale, the vice president now owns 1,154 shares in the company, valued at $318,342.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Allan E. Rubenstein sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.37, for a total value of $398,055.00. Following the transaction, the director now directly owns 3,068 shares in the company, valued at approximately $814,155.16. The disclosure for this sale can be found here. Insiders have sold 20,691 shares of company stock worth $5,527,869 in the last quarter. 1.60% of the stock is currently owned by corporate insiders.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: What is the Consumer Price Index (CPI)?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.